GlassScriptPhysician profile
Tekchand Ramchand
NPI 1265852198
$743.58
in general payments reported to CMS, 2019-2025
8 companies · $25.57 in 2025
The $25.57 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $92.52 · 2021: $39.52 · 2022: $302 · 2023: $224 · 2024: $60.19 · 2025: $25.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $383.32 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $114.33 | 2021-2023 | |
| Philips North America LLC | $75.10 | 2020 | |
| Haemonetics Corporation | $51.00 | 2022 | |
| W. L. Gore & Associates, INC. | $48.23 | 2022-2024 | Viatorr Tips Endoprosthesis W/ Controlled Expansion |
| Terumo Medical Corporation | $28.61 | 2024 | Glidewire, Tr Band, Navicross |
| Stryker Corporation | $25.57 | 2025 | Flowtriever |
| Medtronic Vascular, INC. | $17.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tekchand Ramchand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.